At a glance
ClinicalIndex Comparison RecordN/ACompleted· 50 enrolled
Drug / intervention
InSeca Stylusdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Evaluation of Low Power Radiofrequency Energy Applied to the Posterior Nasal Nerve Area for Symptomatic Relief of Chronic Rhinitis
In Brief
A clinical study evaluating InSeca Stylus for Chronic Rhinitis. Completed, enrolled 50 participants across 5 sites.
Detailed Summary
Evaluation of the Aerin Medical Device used for the treatment of chronic rhinitis
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Rhinitis
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartOct 2018
First PostedNov 2018
Primary CompletionFeb 2020
Study CompletionSep 2020
TodayJul 2026
First PostedNov 1, 2018
Enrollment StartOct 16, 2018
Primary CompletionFeb 1, 2020
Study CompletionSep 17, 2020
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 7.7 years ago
Interventions
InSeca Stylusdevice
Low power radiofrequency energy delivery to the portion of the nasal cavity mucosa overlying the region of the posterior nasal nerve (the posterior middle meatus and posterior inferior meatus).